IBDEI1DU ; ; 19-NOV-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,23057,0)
 ;;=F03.90^^107^1087^15
 ;;^UTILITY(U,$J,358.3,23057,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,23057,1,3,0)
 ;;=3^Dementia w/o Behav Disturb,Unspec
 ;;^UTILITY(U,$J,358.3,23057,1,4,0)
 ;;=4^F03.90
 ;;^UTILITY(U,$J,358.3,23057,2)
 ;;=^5003050
 ;;^UTILITY(U,$J,358.3,23058,0)
 ;;=F01.51^^107^1087^30
 ;;^UTILITY(U,$J,358.3,23058,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,23058,1,3,0)
 ;;=3^Vascular Dementia w/ Behav Disturb
 ;;^UTILITY(U,$J,358.3,23058,1,4,0)
 ;;=4^F01.51
 ;;^UTILITY(U,$J,358.3,23058,2)
 ;;=^5003047
 ;;^UTILITY(U,$J,358.3,23059,0)
 ;;=F01.50^^107^1087^31
 ;;^UTILITY(U,$J,358.3,23059,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,23059,1,3,0)
 ;;=3^Vascular Dementia w/o Behav Disturb
 ;;^UTILITY(U,$J,358.3,23059,1,4,0)
 ;;=4^F01.50
 ;;^UTILITY(U,$J,358.3,23059,2)
 ;;=^5003046
 ;;^UTILITY(U,$J,358.3,23060,0)
 ;;=A81.9^^107^1087^6
 ;;^UTILITY(U,$J,358.3,23060,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,23060,1,3,0)
 ;;=3^Atypical Virus Infection of CNS,Unspec
 ;;^UTILITY(U,$J,358.3,23060,1,4,0)
 ;;=4^A81.9
 ;;^UTILITY(U,$J,358.3,23060,2)
 ;;=^5000414
 ;;^UTILITY(U,$J,358.3,23061,0)
 ;;=A81.09^^107^1087^8
 ;;^UTILITY(U,$J,358.3,23061,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,23061,1,3,0)
 ;;=3^Creutzfeldt-Jakob Disease NEC
 ;;^UTILITY(U,$J,358.3,23061,1,4,0)
 ;;=4^A81.09
 ;;^UTILITY(U,$J,358.3,23061,2)
 ;;=^5000410
 ;;^UTILITY(U,$J,358.3,23062,0)
 ;;=A81.00^^107^1087^9
 ;;^UTILITY(U,$J,358.3,23062,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,23062,1,3,0)
 ;;=3^Creutzfeldt-Jakob Disease,Unspec
 ;;^UTILITY(U,$J,358.3,23062,1,4,0)
 ;;=4^A81.00
 ;;^UTILITY(U,$J,358.3,23062,2)
 ;;=^5000409
 ;;^UTILITY(U,$J,358.3,23063,0)
 ;;=A81.01^^107^1087^10
 ;;^UTILITY(U,$J,358.3,23063,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,23063,1,3,0)
 ;;=3^Creutzfeldt-Jakob Disease,Variant
 ;;^UTILITY(U,$J,358.3,23063,1,4,0)
 ;;=4^A81.01
 ;;^UTILITY(U,$J,358.3,23063,2)
 ;;=^336701
 ;;^UTILITY(U,$J,358.3,23064,0)
 ;;=A81.89^^107^1087^7
 ;;^UTILITY(U,$J,358.3,23064,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,23064,1,3,0)
 ;;=3^Atypical Virus Infections of CNS NEC
 ;;^UTILITY(U,$J,358.3,23064,1,4,0)
 ;;=4^A81.89
 ;;^UTILITY(U,$J,358.3,23064,2)
 ;;=^5000413
 ;;^UTILITY(U,$J,358.3,23065,0)
 ;;=A81.2^^107^1087^27
 ;;^UTILITY(U,$J,358.3,23065,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,23065,1,3,0)
 ;;=3^Progressive Multifocal Leukoencephalopathy
 ;;^UTILITY(U,$J,358.3,23065,1,4,0)
 ;;=4^A81.2
 ;;^UTILITY(U,$J,358.3,23065,2)
 ;;=^5000411
 ;;^UTILITY(U,$J,358.3,23066,0)
 ;;=B20.^^107^1087^17
 ;;^UTILITY(U,$J,358.3,23066,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,23066,1,3,0)
 ;;=3^HIV Disease w/ Dementia w/ Behav Disturb
 ;;^UTILITY(U,$J,358.3,23066,1,4,0)
 ;;=4^B20.
 ;;^UTILITY(U,$J,358.3,23066,2)
 ;;=^5000555^F02.81
 ;;^UTILITY(U,$J,358.3,23067,0)
 ;;=B20.^^107^1087^18
 ;;^UTILITY(U,$J,358.3,23067,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,23067,1,3,0)
 ;;=3^HIV Disease w/ Dementia w/o Behav Disturb
 ;;^UTILITY(U,$J,358.3,23067,1,4,0)
 ;;=4^B20.
 ;;^UTILITY(U,$J,358.3,23067,2)
 ;;=^5000555^F02.80
 ;;^UTILITY(U,$J,358.3,23068,0)
 ;;=F10.27^^107^1087^1
 ;;^UTILITY(U,$J,358.3,23068,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,23068,1,3,0)
 ;;=3^Alcohol Dependence w/ Alcohol-Induced Persisting Dementia
 ;;^UTILITY(U,$J,358.3,23068,1,4,0)
 ;;=4^F10.27
 ;;^UTILITY(U,$J,358.3,23068,2)
 ;;=^5003095
 ;;^UTILITY(U,$J,358.3,23069,0)
 ;;=F19.97^^107^1087^29
 ;;^UTILITY(U,$J,358.3,23069,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,23069,1,3,0)
 ;;=3^Psychoactive Substance Use w/ Persisting Dementia NEC
